Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

Immunity

Volumn 42, Issue 3, 2015, Pages 443-456

  Schlums, Heinrich ^a   Cichocki, Frank ^a,b   Tesi, Bianca ^a   Theorell, Jakob ^a   Beziat, Vivien ^a   Holmes, Tim D ^a   Han, Hongya ^a   Chiang, Samuel C C ^a   Foley, Bree ^b   Mattsson, Kristin ^a   Larsson, Stella ^a   Schaffer, Marie ^a   Malmberg, Karl Johan ^a,c,d   Ljunggren, Hans Gustaf ^a   Miller, Jeffrey S ^b   Bryceson, Yenan T ^a,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FC EPSILON RECEPTOR GAMMA; FC RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PLZF; UNCLASSIFIED DRUG; ANTIBODY; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; KLRC2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SH2D1B PROTEIN, HUMAN; SIGNAL PEPTIDE; ZBTB16 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA METHYLATION; EFFECTOR CELL; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; CELL PROLIFERATION; CLASSIFICATION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DEFICIENCY; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; MICROARRAY ANALYSIS; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ADAPTIVE IMMUNITY; ANTIBODIES; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GPI-LINKED PROTEINS; HUMANS; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICROARRAY ANALYSIS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTORS;

EID: 84924984567     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.02.008     Document Type: Article

References (50)

1. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
2. Arsenio J., Kakaradov B., Metz P.J., Kim S.H., Yeo G.W., Chang J.T. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat. Immunol. 2014, 15:365-372.
3. Beaulieu A.M., Zawislak C.L., Nakayama T., Sun J.C. The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 2014, 15:546-553.
4. Béziat V., Liu L.L., Malmberg J.A., Ivarsson M.A., Sohlberg E., Björklund A.T., Retière C., Sverremark-Ekström E., Traherne J., Ljungman P., et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013, 121:2678-2688.
5. Bezman N.A., Kim C.C., Sun J.C., Min-Oo G., Hendricks D.W., Kamimura Y., Best J.A., Goldrath A.W., Lanier L.L., Gautier E.L., et al. Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 2012, 13:1000-1009. Immunological Genome Project Consortium.
6. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N.Engl. J. Med. 1989, 320:1731-1735.
7. Björkström N.K., Riese P., Heuts F., Andersson S., Fauriat C., Ivarsson M.A., Björklund A.T., Flodström-Tullberg M., Michaëlsson J., Rottenberg M.E., et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-3864.
8. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 2006, 214:73-91.
9. Buchholz V.R., Flossdorf M., Hensel I., Kretschmer L., Weissbrich B., Gräf P., Verschoor A., Schiemann M., Höfer T., Busch D.H. Disparate individual fates compose robust CD8+ Tcell immunity. Science 2013, 340:630-635.
10. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
11. Cichocki F., Miller J.S., Anderson S.K., Bryceson Y.T. Epigenetic regulation of NK cell differentiation and effector functions. Front. Immunol. 2013, 4:55.
12. Constantinides M.G., McDonald B.D., Verhoef P.A., Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014, 508:397-401.
13. Crouse J., Bedenikovic G., Wiesel M., Ibberson M., Xenarios I., Von Laer D., Kalinke U., Vivier E., Jonjic S., Oxenius A. Type I interferons protect Tcells against NK cell attack mediated by the activating receptor NCR1. Immunity 2014, 40:961-973.
14. Eidson M., Wahlstrom J., Beaulieu A.M., Zaidi B., Carsons S.E., Crow P.K., Yuan J., Wolchok J.D., Horsthemke B., Wieczorek D., Sant'Angelo D.B. Altered development of NKT cells, γδ Tcells, CD8 Tcells and NK cells in a PLZF deficient patient. PLoS ONE 2011, 6:e24441.
15. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J.Exp. Med. 2002, 195:343-351.
16. Firth M.A., Madera S., Beaulieu A.M., Gasteiger G., Castillo E.F., Schluns K.S., Kubo M., Rothman P.B., Vivier E., Sun J.C. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J.Exp. Med. 2013, 210:2981-2990.
17. Foley B., Cooley S., Verneris M.R., Pitt M., Curtsinger J., Luo X., Lopez-Vergès S., Lanier L.L., Weisdorf D., Miller J.S. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012, 119:2665-2674.
18. Gascoyne D.M., Long E., Veiga-Fernandes H., de Boer J., Williams O., Seddon B., Coles M., Kioussis D., Brady H.J. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009, 10:1118-1124.
19. Gerlach C., Rohr J.C., Perié L., van Rooij N., van Heijst J.W., Velds A., Urbanus J., Naik S.H., Jacobs H., Beltman J.B., et al. Heterogeneous differentiation patterns of individual CD8+ Tcells. Science 2013, 340:635-639.
20. Gleimer M., von Boehmer H., Kreslavsky T. PLZF controls the expression of a limited number of genes essential for NKT cell function. Front. Immunol. 2012, 3:374.
21. Green M.L., Leisenring W.M., Xie H., Walter R.B., Mielcarek M., Sandmaier B.M., Riddell S.R., Boeckh M. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 2013, 122:1316-1324.
22. Gumá M., Angulo A., Vilches C., Gómez-Lozano N., Malats N., López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
23. Hesslein D.G., Palacios E.H., Sun J.C., Beilke J.N., Watson S.R., Weiss A., Lanier L.L. Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. Blood 2011, 117:3087-3095.
24. Hwang I., Zhang T., Scott J.M., Kim A.R., Lee T., Kakarla T., Kim A., Sunwoo J.B., Kim S. Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. Int. Immunol. 2012, 24:793-802.
25. Ito S., Pophali P., Co W., Koklanaris E.K., Superata J., Fahle G.A., Childs R., Battiwalla M., Barrett A.J. CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant. 2013, 48:1313-1316.
26. Juelke K., Killig M., Luetke-Eversloh M., Parente E., Gruen J., Morandi B., Ferlazzo G., Thiel A., Schmitt-Knosalla I., Romagnani C. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010, 116:1299-1307.
27. Khakoo S.I., Rajalingam R., Shum B.P., Weidenbach K., Flodin L., Muir D.G., Canavez F., Cooper S.L., Valiante N.M., Lanier L.L., Parham P. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 2000, 12:687-698.
28. Kolanus W., Romeo C., Seed B. T cell activation by clustered tyrosine kinases. Cell 1993, 74:171-183.
29. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer Tcell effector functions. Nat. Immunol. 2008, 9:1055-1064.
30. Kreslavsky T., Savage A.K., Hobbs R., Gounari F., Bronson R., Pereira P., Pandolfi P.P., Bendelac A., von Boehmer H. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta Tcells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 2009, 106:12453-12458.
31. Kuijpers T.W., Baars P.A., Dantin C., van den Burg M., van Lier R.A., Roosnek E. Human NK cells can control CMV infection in the absence of Tcells. Blood 2008, 112:914-915.
32. Lee S.U., Maeda T. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol. Rev. 2012, 247:107-119.
33. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013, 31:227-258.
34. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011, 108:14725-14732.
35. Mathew R., Seiler M.P., Scanlon S.T., Mao A.P., Constantinides M.G., Bertozzi-Villa C., Singer J.D., Bendelac A. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 2012, 491:618-621.
36. Oikawa Y., Matsuda E., Nishii T., Ishida Y., Kawaichi M. Down-regulation of CIBZ, a novel substrate of caspase-3, induces apoptosis. J.Biol. Chem. 2008, 283:14242-14247.
37. Puszyk W., Down T., Grimwade D., Chomienne C., Oakey R.J., Solomon E., Guidez F. The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells. EMBO J. 2013, 32:1941-1952.
38. Rook A.H. Interactions of cytomegalovirus with the human immune system. Rev. Infect. Dis. 1988, 10(3):S460-S467.
39. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
40. Scharer C.D., Barwick B.G., Youngblood B.A., Ahmed R., Boss J.M. Global DNA methylation remodeling accompanies CD8 Tcell effector function. J.Immunol. 2013, 191:3419-3429.
41. Stemberger C., Huster K.M., Koffler M., Anderl F., Schiemann M., Wagner H., Busch D.H. A single naive CD8+ Tcell precursor can develop into diverse effector and memory subsets. Immunity 2007, 27:985-997.
42. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
43. Toyoda S., Kawaguchi M., Kobayashi T., Tarusawa E., Toyama T., Okano M., Oda M., Nakauchi H., Yoshimura Y., Sanbo M., et al. Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity. Neuron 2014, 82:94-108.
44. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
45. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
46. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral Tcells. Nature 2012, 481:394-398.
47. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell 1994, 76:263-274.
48. Xu D., Holko M., Sadler A.J., Scott B., Higashiyama S., Berkofsky-Fessler W., McConnell M.J., Pandolfi P.P., Licht J.D., Williams B.R. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity 2009, 30:802-816.
49. Xu H.C., Grusdat M., Pandyra A.A., Polz R., Huang J., Sharma P., Deenen R., Köhrer K., Rahbar R., Diefenbach A., et al. Type I interferon protects antiviral CD8+ Tcells from NK cell cytotoxicity. Immunity 2014, 40:949-960.
50. Zhang T., Scott J.M., Hwang I., Kim S. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J.Immunol. 2013, 190:1402-1406.